Transpara (2.1.0)
Radiological Computer Assisted Detection/Diagnosis Software For Lesions Suspicious For Cancer. 510(k) K260898, from Screenpoint Medical B.V. (Nijmegen, NL). Product code QDQ, class 2.
As of Nov 16, 2026, K260898 is an FDA 510(k) held by Screenpoint Medical B.V., substantially equivalent on Aug 14, 2026 after 149 days, with no recalls tied to it in FDA's recall database.
- Substantially equivalent: Aug 14, 2026
- Review time: 149 days
- Recalls: 0
Other QDQ Clearances
The newest 510(k)s for the same product code; their median review was 159 days; see every QDQ device- qCT Lung (v1.0)K261517 · Qure.Ai Technologies Pvt. , Ltd. · Sep 14, 2026
- CadAI-B DxK260086 · BeamWorks, Inc. · Aug 12, 2026
- See-Mode Augmented Reporting Tool, Breast (SMART-B)K260303 · See-Mode Technologies Pty, Ltd. · Jul 28, 2026
- MammoScreen® (5)K260714 · Therapixel · Jun 26, 2026
- Saige-DxK253825 · DeepHealth, Inc. · Jun 15, 2026
- DeepHealth ProstateAIK253682 · Quantib B.V. · Apr 29, 2026
- Lunit INSIGHT MMG (v1.1.10)K260320 · Lunit, Inc. · Apr 23, 2026
- Lunit INSIGHT DBT (V1.2)K253796 · Lunit, Inc. · Mar 26, 2026
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Special
- Received
- Mar 18, 2026
- Review panel
- Radiology
- Regulation
- 21 CFR 892.2090
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. openFDA device 510(k), PMA and recall files